ZEVALIN® » Learn about ZEVALIN | ZEVALIN® (ibritumomab tiuxetan) « non-hodgkin-s-lymphoma

(Kliknięcia: 203;Dodana witryna: May 21, 2015, non-hodgkin-s-lymphoma)

ZEVALIN is a CD20-directed radiotherapeutic antibody administered as part of the ZEVALIN therapeutic regimen indicated for the treatment of patients with: Relapsed or refractory, low-grade or follicular B-cell non-Hodgkin's lymphoma (NHL). Previously

zevalin non hodgkin s lymphoma follicular nhl spectrum pharmaceuticals